eli lilly glp-1 advantage decreasing Lilly's weight-loss drug reduces sleep apnea severity in late-stage trials Pharma Giants Bet on Next-Generation

In commercial plans and employer groups, adoption is accelerating: a 2025 Health Affairs/KFF survey found that 43% of firms with 5,000+ employees now cover GLP-1s for weight loss, up from 28% in 2024 ( [26] ), and 57% of employers overall cover GLP-1s for weight loss according to WTW survey data ( [27] )

Percents do not add up to 100% due to the ability to select multiple options

in fact, they celebrated their first anniversary by inviting a Wellstar Georgia Cancer Center patient and breast team nurse navigator to come and share their story

Cyclical or targeted variations may be useful during the maintenance phase or for highly active individuals whose training demands benefit from periodic carbohydrate availability